
usd may pm et
summari corpor largest pharmaci health care provid
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
may pm stock trade
earli began test first
remodel store healthhub texa
store expand health care
servic offer aim help patient
avoid hospit better manag
health intend expand healthhub
locat view
posit also encourag
effort drive engag
custom nationwid expans
carepass subscript program
clinic trial home hemodialysi system
commerci launch expect late
text messag program
aetna merger debt suspend
share repurchas dividend increas
compani achiev leverag ratio debt
debt taken strengthen financi
posit pandem
commit lower leverag low
strong free cash flow
estim leverag ratio
march decemb
expect adjust oper incom
improv billion margin
vs
believ share trade
ep sever
under-valued due relat
stay-at-hom quarantin measur
expect see signific declin front
store sale anticip short-term
shock impact posit long-term
view think fare rel well
recess peopl continu
need access health care product
servic regardless econom condit
opinion cvs-aetna aet combin
tremend upsid potenti
aet grow exposur medicar
advantag plan grew industri
averag redesign in-stor
experi pharmaci custom
grow array health care servic offer
believ continu transform
effort support ep growth acceler
next year
risk recommend price includ
integr difficulti failur improv
patient care increas industri regul
target appli forward
price-to-earnings multipl ep
risk assess reflect compani leadership
posit strong market share rel stabl
 retail drug industri pharmaci benefit
manag pbm somewhat off-set
acquisition-integr risk elev debt level
growth non-tradit competitor
aug ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
gener counsel
corpor overview health corpor oper one largest drug store chain
pharmaci benefit manag base revenu net incom store count drug store offer
prescript drug wide assort gener merchandis includ over-the-counter drug beauti product
cosmet film photo finish servic season merchandis greet card conveni
servic plan design administr formulari manag claim process report
segment retail/ltc long-term care segment pharmaci servic segment pbm
acquisit insur aetna aet also oper one largest insur
 fall health benefit hcb segment establish acquisit
aet acquisit aet also result silverscript busi move hcb segment
acquir pharmaci oper aet consolid pharmaci servic busi
market profil decemb oper retail locat approxim
walk-in health care clinic lead pharmaci benefit manag million plan
member oper state district columbia puerto rico brazil fill
billion prescript billion fill retail/ltc segment account
 retail pharmaci market
pharmaci servic segment provid full rang pharmaci benefit manag pbm servic
includ oper mail order pharmaci specialti pharmaci medicar part servic
formulari manag discount drug purchas agreement busi gener billion
sale billion oper incom part pharmaci servic segment
specialti pharmaci busi oper retail specialti pharmaci store specialti mail order
pharmaci mail servic pharmaci
retail/ltc segment gener revenu billion oper incom million
retail/ltc segment revenu compris pharmaci retail segment revenu
front store revenu front store categori includ over-the-count
drug beauti product cosmet person care product conveni food among
product proprietari brand product account approxim compani front store
revenu also one largest oper retail health care clinic clinic
diagnos treat minor health condit perform health screen monitor chronic condit
hcb segment lead health care benefit provid serv estim million
peopl decemb health benefit segment offer broad rang tradit
voluntari consumer-direct health insur product relat servic includ medic
pharmaci dental behavior health medic manag capabl medicar advantag medicar
administr servic health inform technolog hit product servic
corpor strategi pharmaci servic busi strategi center provid innov tool
strategi well qualiti client servic help improv clinic outcom client plan
member assist better pharmaci manag overal health care cost aim
leverag expertis core pbm servic includ plan design offer administr
formulari manag medicar part servic mail order specialti pharmaci infus servic
diseas manag servic medic spend manag
earli began test first remodel store healthhub texa store
expand health care servic offer aim help patient avoid hospit better manag
health upon initi success healthhub model announc intent
expand healthhub metro area locat end
one key retail pharmaci busi strategi technolog allow focu
constantli improv servic explor way provid person product offer
servic continu leverag digit tool empow custom patient make full
breadth health care pharmaci servic avail anytim anywher also continu
introduc digit tool make easier peopl save time money live healthier live
roll pay nationwid end-to-end mobil payment solut integr
payment prescript pick-up extracar loyalti program one spot checkout
impact major develop agre acquir third largest health insur
aetna aet total enterpris valu billion decemb combin close
late make strateg sens us provid greater abil incent aetna larg
popul health plan particip util caremark mail order system retail store
financi trend sale grew five-year compound annual growth rate compound-annual-growth-rate
billion year end decemb adjust ep grew slightli higher five-year compound-annual-growth-rate
free cash flow measur cash flow oper less capit expenditur billion
billion billion septemb net
debt capit ratio expect compani focu reduc immens free
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
under-valued usd
bullish sinc may technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
outlook health care servic
sub-industri next year neg
recess concern
impact expect demand typic health care
servic declin significantli yoy
peopl stay home health care
system focu shift address
exampl comment late march
anesthesiolog busi experienc
signific declin elect surgeri
volum driven closur oper
suit facil yet
opportun exampl lab
test provid labcorp quest
relat test
long term even weak macroeconom
condit persist expect demand health
care servic remain rel steadi
compar industri
import health care consum prior
profit health care
servic compani pressur recent
year factor rise wage labor
legislative/regulatori initi
difficult determin rise unemploy
relat effect affect
pressur
believ long-term trend rise
health care spend
incentiv legisl regul
find way control cost health care
servic industri easi target
cost cut exampl initi lower
health care cost includ trump initi
chang payment model dialysi treatment
bipartisan effort tackl surpris bill
unclear chang dialysi
payment affect firm like
long run believ surpris bill
legisl like neg impact
physician outsourc group mednax
limit physician reimburs
struck individu mandat
associ afford act
howev court avoid determin
much remain valid believ
outcom remov possibl
worst-cas scenario health care servic
firm complet
gener benefit increas
insur coverag past sever year
elimin certain provis
could neg impact
industri earli suprem court
agre hear case decis
case like made
earliest believ suprem
court allow remain
minim impact health care
prior anticip
sub-industri ep growth
estim growth rate given
fluiditi volatil current
situat await earn commentari
updat ep expect health
march
declin composit index
 health servic index
gain vs increas
base index
five-year market price perform may
note sector sub-industri inform base
past perform indic futur perform
reli upon
laboratori corpor america
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
corpor rais target price base
multipl ep ep vs
exceed estim primarili due net realiz capit gain
favor prior year develop lift ep
lower ep overal strong quarter
support posit long-term outlook share adjust oper incom
billion expect yoy debt paydown progress
faster anticip compani repaid billion net debt sinc
acquisit aetna vs expect billion paid
eight month healthhub test houston
store outperform control group term prescript volum
front store sale foot traffic margin increas confid
plan rapidli roll-out healthhub across /kevin huang cfa
et cfra lower opinion health marketweight
overweight lower recommend exposur
sector marketweight overweight group tradit
perform well tradit lacklust summer month keep
pace overal market remaind year besid alreadi
trade elev valuat particularli best perform
sub-industri medic technolog life scienc tool think
group contend increas political/regulatori risk
presidenti elect cycl get full swing final group
below-averag percentag favor constitu invest recommend
analyst research note compani news
et cfra reiter strong buy opinion share
corpor lift target price
base multipl ep estim ep
vs higher estim due strong core busi
perform estim benefit elev consum demand
relat lift ep estim
encourag hear maintain earn cash flow guidanc
year healthhub convers paus continu expect
convert store healthhub end cvss recent
consum engag digit effort demonstr signific payoff
carepass subscript program grew sequenti million member
retail prescript home deliveri increas yoy telemedicin visit
increas approxim yoy think well posit
weather upcom volatil serv custom wide array
pm et cfra maintain strong buy opinion share
corpor lower price target share
incorpor view impact given
walgreen commentari today expect experi
short-term boost front store sale toward end follow
signific declin substanti lower outlook earn
dynam primarili driven stay-at-hom quarantin measur
short-term shock impact long-term view less
expos front store sale also pbm manag
care busi remain track pay debt expand healthhub
model think fare rel well recess
peopl continu need access health care product servic
regardless econom condit cut ep estim
ep also lower forward price-to-earnings
multipl reflect broad multipl compress /kevin huang
et cfra rais opinion health overweight
marketweight rais recommend exposur
sector overweight marketweight sector defens
characterist support absolut rel valuat
trade double-digit discount long-term averag sector oper ep
growth estim versu gain project
 addit group roll rel strength
posit trend sinc sector less neg impact
group final cfra proprietari reward rate input
correspond sector etf slightli posit driven
rel attract underli hold recent
et cfra keep strong buy opinion share
corpor lift target price
base multipl ep estim ep
vs higher estim lower ep
initi ep adjust oper
incom billion slightli expect revenu
billion almost billion higher expect meanwhil
cvss guidanc mostli line outlook compani
on-track better achiev promis integr synergi enterpris
modern benefit debt paydown leverag ratio debt ttm
ebitda low estim cvss leverag
ratio continu remain convinc cvss
long-term valu proposit support compani transform
progress far includ new offer rxzero addit
higher util cvss health care servic digit offer
et cfra reiter strong buy opinion share
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
redistribut reproduct prohibit without prior written permiss copyright cfra
content includ rate credit-rel analys data valuat model softwar
applic output therefrom part thereof content may modifi
revers engin reproduc distribut form mean store
databas retriev system without prior written permiss cfra content shall
use unlaw unauthor purpos cfra third-parti provid
well director offic sharehold employe agent guarante
accuraci complet timeli avail content
past perform necessarili indic futur result
document may contain forward-look statement forecast forecast
reliabl indic futur perform
report intend constitut offer solicit buy sell
secur engag invest activ report inform purpos
recommend report made respect particular investor
type investor secur financi instrument strategi mention herein may
suitabl investor materi intend specif investor
take account investor particular invest object financi situat
need act recommend materi consid whether
suitabl particular circumst necessari seek profession advic
cfra may licens certain intellectu properti provid servic otherwis
busi relationship certain issuer secur subject cfra
research report includ exchange-trad invest whose invest object
substanti replic return proprietari index cfra case cfra
paid fee tie amount asset invest fund volum trade
activ fund invest fund may result cfra receiv compens
addit subscript fee compens servic render cfra
howev part cfra compens servic tie recommend
rate addit inform subject compani may avail upon request
cfra financi data provid global market intellig document contain
global industri classif standard gic develop and/or exclus
properti inc global market intellig gic servic mark
 global market intellig licens use cfra
disclaim notic
certain inform report provid global inc and/or affili
subsidiari collect global inform subject follow
disclaim notic copyright global market intellig affili
applic right reserv noth contain herein invest advic
refer particular invest secur credit rate observ
concern secur invest provid recommend buy
sell hold invest secur make invest decis may
contain inform obtain third parti includ rate credit rate
agenc reproduct distribut inform third parti content
form prohibit except prior written permiss global
relat third parti applic neither third parti provid guarante
accuraci complet timeli avail inform includ rate
respons error omiss neglig otherwis regardless
caus result obtain use inform content
includ rate credit rate statement opinion statement
fact recommend purchas hold sell secur address
suitabl secur suitabl secur invest purpos
reli invest advic
